Evidence map›Paper›PMID 40625730›Full record

ArticleRSC advances2025

Mn and Cu complexes of a novel malic acid-cysteine ligand with remarkable ROS scavenging activity.

Saeedeh Khadivi-Derakhshan, Mahtab Pirouzmand, Jafar Soleymani, Mehdi D Esrafili

Abstract read
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Saeedeh Khadivi-DerakhshanDepartment of Inorganic Chemistry, Faculty of Chemistry, University of Tabriz Tabriz 5166616471 Iran m.pirouzmand@tabrizu.ac.ir.
Mahtab PirouzmandDepartment of Inorganic Chemistry, Faculty of Chemistry, University of Tabriz Tabriz 5166616471 Iran m.pirouzmand@tabrizu.ac.ir.ORCID https://orcid.org/0000-0002-9961-7945
Jafar SoleymaniPharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences Tabriz Iran.ORCID https://orcid.org/0000-0002-8316-5104
Mehdi D EsrafiliDepartment of Chemistry, Faculty of Basic Sciences, University of Maragheh Maragheh Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The scientific community is very interested in investigating antioxidant activity using various assays to treat oxidative stress and reduce the harmful effects of free radicals. Cysteine, a sulfur-containing compound can treat oxidative stress. The primary objective of this study was to create a novel ligand through the combination of l-cysteine with malic acid and its metal complexes with copper and manganese. The following discussion focuses on how the complexes mimic natural antioxidant enzymes and explains how they could be used to remove reactive oxygen species. Various methods were used to verify the synthesis, including FT-IR, UV-vis, TGA, CHNS, EDX, SEM, mass, and fluorescence. These techniques indicated structural changes upon complexation and integration with β-CD. Spectrophotometric tests were used to evaluate the compounds' peroxidase-, catalase-, and superoxide dismutase-like activities under different conditions. Cytotoxicity was evaluated using HFF-2 cells and the MTT test. The amounts of carbon, hydrogen, nitrogen, and sulfur were 39.48, 4.7, 6.58, and 15.23, and the ligand formula is C

Identifiers

PMID40625730
PMCPMC12231885

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.